New Delhi: In a big assistance for travelers from India, Canada will recognize Bharat Biotech’s Covaxin from November 30, 2021.
The North American country has expanded the Covid-19 list which will be accepted to travel to and in Canada from the end of the moth by adding synopharm (Also referred to as Covilo), Sinovac (also referred to as Coronavac) and covaxin made-in-India.
Tourists will qualify as fully vaccinated if they have received at least 2 doses of the Covid-19 vaccine received by Canada or a mixture of 2 vaccines received, or at least 1 dose of Janssen / Johnson vaccine & Johnson, at least 14 full days before entering Canada.
“Starting November 30, vaccination will be needed for travel inside and outside Canada.
Covid-19 molecular tests that are valid will no longer be accepted as alternative vaccinations unless the travelers are qualified for one limited exception, such as medical inability to vaccinate.
Tourists must contact The airline or train company is to get the necessary form and submit it according to the process of their operator’s approval on November 30, “said a statement of the Canadian government on Friday (November 19).
A leading travel agent said remembering the covid situation far in India, all eyes now light up when Canada allows direct flights from other cities here because currently only tourists who are fully vaccinated who do tests in Delhi airport lab are allowed to take a flight to Delhi from IGI airport.
And also when Canada eliminates the requirements of someone who flew from India to Canada through a third country that requires a negative report from the Covid test conducted in the transit country is very much awaited.
“So both these limits are removed, we can expect trips – and rates – to proceed to near normal.
Today every person who qualifies to travel from India to Canada must do it through Delhi,” said travel agent.
Canada to receive Covaxin from November 30
